Crinetics Pharmaceuticals, Inc. (CRNX)
NASDAQ: CRNX · Real-Time Price · USD
38.15
-0.47 (-1.22%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Crinetics Pharmaceuticals Market Cap
Crinetics Pharmaceuticals has a market cap or net worth of $3.99 billion as of April 29, 2026. Its market cap has increased by 59.89% in one year.
Market Cap
3.99B
Enterprise Value
3.02B
1-Year Change
59.89%
Ranking
Category
Stock Price
$38.15
Market Cap Chart
Since July 18, 2018, Crinetics Pharmaceuticals's market cap has increased from $563.93M to $3.99B, an increase of 608.34%. That is a compound annual growth rate of 28.61%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Amicus Therapeutics | 4.55B |
| Legend Biotech | 4.23B |
| Oruka Therapeutics | 4.08B |
| Veradermics | 3.96B |
| Viking Therapeutics | 3.89B |
| ACADIA Pharmaceuticals | 3.83B |
| Travere Therapeutics | 3.80B |
| Tango Therapeutics | 3.65B |